Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling

被引:5
|
作者
Redondo, Alfredo [1 ,2 ]
Paradela-Dobarro, Beatriz [3 ,4 ]
Moscoso, Isabel [3 ,4 ]
Moure-Alvarez, Maria [1 ,2 ]
Cebro-Marquez, Maria [3 ]
Gonzalez-Juanatey, Jose Ramon [1 ,2 ,3 ,4 ]
Garcia-Seara, Javier [1 ,2 ,3 ,4 ]
Alvarez, Ezequiel [4 ,5 ]
机构
[1] Complexo Hosp Univ Santiago de Compostela CHUS, Serv Cardiol, SERGAS, Travesia Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain
[2] Complexo Hosp Univ Santiago de Compostela CHUS, Unidad Hemodinam, SERGAS, Travesia Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain
[3] Complexo Hosp Univ Santiago de Compostela CHUS, Unidad Hemodinam, Inst Invest Sanitaria Santiago de Compostela IDIS, Travesia Choupana S-N, Santiago De Compostela 15706, A Coruna, Spain
[4] CIBERCV, Madrid, Spain
[5] Complexo Hosp Univ Santiago de Compostela CHUS, Lab 6, Inst Invest Sanitaria Santiago de Compostela IDIS, SERGAS, Edif Consultas Externas,Planta 2, Santiago De Compostela 15706, A Coruna, Spain
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2021年 / 99卷 / 07期
关键词
Acute myocardial infarction with ST-segment elevation; Post-infarction remodeling; Galectin-3; Soluble RAGE; Biomarkers; GLYCATION END-PRODUCTS; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; SERUM GALECTIN-3; HEART-FAILURE; RECEPTOR; FIBROSIS; EXPRESSION; S100B; ASSOCIATION;
D O I
10.1007/s00109-021-02054-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Post-infarction remodeling is a clinical problem with no curative treatment. Our objective was to search for new biomarkers of cardiac remodeling that have clinical value after ST-segment elevation myocardial infarction (STEMI). This pilot study enrolled 67 consecutive patients with de novo STEMI who underwent revascularization by primary angioplasty. Echocardiography studies of cardiac function were completed during the first 48 h post-STEMI and after 6 months of follow-up. Galectin-3 and soluble receptor for advanced glycation end products (sRAGE) were tested in the peripheral venous blood during the 24 h post-infarction. Cardiac remodeling was defined as changes >= 15% in the left ventricular end-systolic volume (LVESV) or > 10% in the left atrial area (LAA). An inverse association was found between galectin-3 (r(s) = - 0.296; p < 0.001) and sRAGE (r(s) = - 0.327; p < 0.001) levels and the basal left ventricle ejection fraction (LVEF). However, only galectin-3 was directly associated with the increase in LVESV (r(s) = 0.389; p = 0.007) and LVEDV (r(s) = 0.314; p = 0.031) during the follow-up. sRAGE was inversely related to the change in LAA (r(s) = - 0.320; p = 0.032). These data are consistent with galectin-3, but not sRAGE levels, as a predictor of left ventricle remodeling (OR 1.036, 95% CI 1.002-1.071; p = 0.039). Galectin-3 and sRAGE levels that were measured during hospitalization are inversely related to basal LVEF after a STEMI. Galectin-3 levels are a predictor of adverse post-STEMI LV remodeling, whereas sRAGE levels exhibited an inverse relationship with left atrial remodeling. Key messages Post-infarction remodeling is a clinical problem with no curative treatment. New biomarkers for remodeling after acute myocardial infarction were explored. Early post-STEMI galectin-3 and soluble RAGE are inversely related with left ventricle function. Galectin-3 levels were predictors of adverse post-STEMI left ventricle remodeling. Soluble RAGE levels were associated with left atrial remodeling.
引用
收藏
页码:943 / 953
页数:11
相关论文
共 50 条
  • [31] The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis
    Menini, Stefano
    Iacobini, Carla
    Ricci, Carlo
    Fantauzzi, Claudia Blasetti
    Salvi, Laura
    Pesce, Carlo M.
    Relucenti, Michela
    Familiari, Giuseppe
    Taurino, Maurizio
    Pugliese, Giuseppe
    CARDIOVASCULAR RESEARCH, 2013, 100 (03) : 472 - 480
  • [32] Galectin-3 in Acute Myocardial Infarction Patients with Atrial Fibrillation
    Stanojevic, Dragana
    Apostolovic, Svetlana
    Stokanovic, Dragana
    Momcilovic, Stefan
    Jevtovic-Stoimenov, Tatjana
    Salinger-Martinovic, Sonja
    Kostic, Tomislav
    Nikolic, ValentinaN.
    MEDICAL PRINCIPLES AND PRACTICE, 2019, 28 (03) : 284 - 290
  • [33] Galectin-3: a new biomarker for heart failure progression and prognosis
    de Boer, Rudolf A.
    van der Velde, A. Rogier
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2013, 37 (05): : 251 - 260
  • [34] The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling
    Yalcin, Muhammed U.
    Gurses, Kadri M.
    Kocyigit, Duygu
    Canpinar, Hande
    Canpolat, Ugur
    Evranos, Banu
    Yorgun, Hikmet
    Sahiner, Mehmet L.
    Kaya, Ergun B.
    Hazirolan, Tuncay
    Tokgozoglu, Lale
    Oto, Mehmet A.
    Ozer, Necla
    Guc, Dicle
    Aytemir, Kudret
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2015, 26 (06) : 635 - 640
  • [35] Galectin-3 is essential for early wound healing and ventricular remodeling after myocardial infarction in mice
    Gonzalez, German E.
    Cassaglia, Pablo
    Truant, Sofia Noli
    Fernandez, Marisa M.
    Wilensky, Luciana
    Volberg, Veronica
    Malchiodi, Emilio L.
    Morales, Celina
    Gelpi, Ricardo J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (03) : 1423 - 1425
  • [36] Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity
    Martinez-Martinez, Ernesto
    Jurado-Lopez, Raquel
    Valero-Munoz, Maria
    Visitacion Bartolome, Maria
    Ballesteros, Sandra
    Luaces, Maria
    Briones, Ana Maria
    Lopez-Andres, Natalia
    Miana, Maria
    Cachofeiro, Victoria
    JOURNAL OF HYPERTENSION, 2014, 32 (05) : 1104 - 1114
  • [37] Nicorandil alleviates myocardial injury and post-infarction cardiac remodeling by inhibiting Mst1
    Wang, Shanjie
    Fan, Yanhong
    Feng, Xinyu
    Sun, Chuang
    Shi, Zhaofeng
    Li, Tian
    Lv, Jianjun
    Yang, Zhi
    Zhao, Zhijing
    Sun, Dongdong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (01) : 292 - 299
  • [38] The prognostic utility of galectin-3 in patients undergoing cardiac surgery: a scoping review
    Shah, Aryan
    Ding, Yu
    Walji, David
    Rabinovich, Gabriel A.
    Pelletier, Marc
    El-Diasty, Mohammad
    BIOMARKERS, 2024, 29 (07) : 485 - 493
  • [39] Galectin-3 Predicts Left Ventricular Remodeling of Hypertension
    Yao, Yongwei
    Shen, Dongli
    Chen, Rong
    Ying, Chunyang
    Wang, Chenghua
    Guo, Junfang
    Zhang, Guohui
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (06) : 506 - 511
  • [40] Retinoid X receptor agonists alleviate fibroblast activation and post-infarction cardiac remodeling via inhibition of TGF-β1/Smad pathway
    Lin, Xiao-yan
    Chu, Yong
    Zhang, Guo-shan
    Zhang, Hai-lin
    Kang, Kai
    Wu, Min-Xia
    Zhu, Jiang
    Xu, Chang-sheng
    Lin, Jin-xiu
    Huang, Chun-kai
    Chai, Da-jun
    LIFE SCIENCES, 2023, 329